Next |
home / stock / pali / pali message board
Subject | By | Source | When |
---|---|---|---|
bs you out with a loss mtf | peterus | investorshub | 04/06/2023 8:09:43 PM |
Out with small win,next | 81vette | investorshub | 04/06/2023 3:59:05 PM |
Beautiful bottom nab,big accumulation started on 30th, institutional/insider | 81vette | investorshub | 04/05/2023 4:10:49 PM |
News out,phase 3 trial,float 1.36m,short 10%(152,545 shares)ZERO BORROW,(no | 81vette | investorshub | 04/05/2023 4:04:38 PM |
I like the chart. | traderbbc1 | investorshub | 04/04/2023 11:08:35 PM |
pali vs Ther | Jayzp | investorshub | 04/04/2023 10:37:49 PM |
What is the target price for Palisade | skichic | investorshub | 04/03/2023 9:40:57 PM |
Made money selling friday premarket at 3.60s bought | enthalpy | investorshub | 04/03/2023 8:29:50 PM |
fda news in Q2 WILL GO BACK up | peterus | investorshub | 04/03/2023 6:25:44 PM |
That multiplies shares by 50% ruces price 1.75 | IOUBLOKE1 | investorshub | 04/03/2023 6:15:21 PM |
https://stockcharts.com/h-sc/ui?s=pali&p=D&yr=0&mn=6&dy=0&id=p38090673899 htt | surf1944 | investorshub | 04/03/2023 2:22:53 PM |
offering f$cking clowns | peterus | investorshub | 04/03/2023 12:36:09 PM |
PALI: So, PALI wants a KRACKER[/color | Invest-in-America | investorshub | 04/02/2023 3:49:13 PM |
PALI OS 4,503,977 | WHIP THE HORSE | investorshub | 04/01/2023 3:44:13 PM |
znewcar1: $PALI 32% v40,8M c3.52 f4,504M H3.65 ML1.55=LL gapNhod | znewcar1 | investorshangout | 04/01/2023 3:17:59 AM |
to many shorts and fliptards maybe dip AH | peterus | investorshub | 03/31/2023 7:49:48 PM |
would be nice to see a close +4 | peterus | investorshub | 03/31/2023 7:30:14 PM |
PH AH let see | peterus | investorshub | 03/31/2023 7:28:48 PM |
could do 30s with low float | peterus | investorshub | 03/31/2023 7:26:42 PM |
15 | peterus | investorshub | 03/31/2023 7:25:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors” with similar structure to PALI-2108 and PALI-1908 This patent family provides Composition o...
Company has now completed murine and non-murine pivotal nonclinical studies using GMP PALI-2108 drug substance Company has successfully formulated enteric-coated tablets of PALI-2108 and has demonstrated consistent and reliable drug release profiles Company on track to commence Ph...
Live video webcast on Wednesday, June 26 th at 4:00 PM ET Carlsbad, CA, June 24, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel...